The World Health Organization has announced the theme for World Patient Safety Day 2024 (September 17) as “Improving diagnosis for patient safety.” World Patient Safety Day is the cornerstone of action to promote global health and safety. It is firmly grounded in the fundamental principle of medicine, “first do no harm.”
To improve diagnostic safety, the main objective for patients and families is to actively engage with health workers and healthcare leaders to improve diagnostic processes.
Here’s what you can do:
Understand and engage in the diagnostic journey.
Ensure you understand the diagnostic process, including the steps that you and your healthcare team will take to determine your diagnosis.
Engage actively with your healthcare team by sharing accurate and comprehensive information about your symptoms and medical history from the start.
Prompt your healthcare team to think comprehensively about alternative diagnoses, such as by asking “What else could it be?”
Ask about the purpose, potential risks, alternatives, and follow-up steps of any recommended diagnostic interventions.
Keep track of your health, symptoms, medical visits, and treatments.
Be informed about the expected progression of your illness, potential danger signs, and how to access care if your condition either does not improve or worsens.
Adhere to prescribed treatment plans and attend follow-up appointments.
Ensure continuity, accuracy, and validity of information.
Ask your healthcare team for information and use reliable medical information sources.
Follow up on the results of your diagnostic tests and proactively ask for the report; no news is not always good news.
Don’t be afraid to seek a second opinion if you have any doubts or uncertainties about the initial diagnosis.
Regularly check your health records to ensure that all information is documented, accurate, and up to date.
Speak up with concerns about your diagnosis and care.
Raise any concerns you may have about your diagnosis or the diagnostic process.
When there is a concerning change in your or your family member’s condition, promptly escalate the issue to your healthcare team.
Contribute to learning and improvement.
Engage in follow-up and provide feedback to your healthcare team about your diagnosis and treatment effectiveness.
Help to improve the wider health system by reporting your experience and suggesting changes.
More Safety Articles
Dramamine brand name will confuse
The brand name Dramamine is the latest example of a well known, over-the-counter (OTC) medicine name being recycled for use in products that contain a different medicine or ingredients that differ from those in the original product. The original Dramamine (regular or chewable) contains 50 mg of dimenhydrinate (Figure 1). But there is now a Dramamine that contains a different medicine called meclizine 25 mg per tablet (Figure 2). And another product, Dramamine Non-Drowsy Naturals, does not contain a drug at all—it’s a supplement that only contains ginger root (Figure 3).
Boric acid suppositories are sometimes used to treat chronic vaginal infections when traditional treatments have failed. Vaginal infections are typically treated with antibiotics, such as metronidazole. For some women, the infection comes back right away. When this happens, some doctors will recommend trying boric acid suppositories.
A doctor prescribed Donnatal (hyoscyamine, atropine, scopolamine, and phenobarbital) for a man who was allergic to one of its ingredients, phenobarbital. Donnatal is used to relax the muscles in the bladder and intestines and to reduce stomach acid. The community pharmacy’s computer system issued a warning about the allergy, but the pharmacist missed seeing the message while entering the prescription into the computer. The doctor also overlooked the allergy even though it was documented in the patient’s chart. The error was discovered by the man while reading the pharmacy provided consumer medication information leaflet, which listed phenobarbital as one of the ingredients. The man did not take the Donnatal.
